| Literature DB >> 35047435 |
Luka Kolar1,2, Marko Stupin2,3,4, Ana Stupin2,4, Petar Šušnjara2,4, Zrinka Mihaljević2,4, Anita Matić2,4, Ivana Jukić2,4, Nikolina Kolobarić2,4, Ines Drenjančević2,4.
Abstract
The present study aimed to determine the effect of n-3 polyunsaturated fatty acid (PUFA)-enriched hen eggs on microvascular vasodilation, microvascular responsiveness to a stress challenge and markers of oxidative stress in competitive athletes. Competitive athletes (n=23) were divided to a control group (n=9), who consumed three regular hens' eggs daily (249 mg n-3 PUFAs/d), and n-3 PUFAs group (n=14), who consumed three n-3 PUFA-enriched hen eggs daily (1,053 g n-3 PUFAs/d) for 3 weeks. Endothelium-dependent responses [post-occlusive reactive hyperemia (PORH) and acetylcholine-induced dilation (AChID)] and endothelium-independent responses [sodium nitroprusside-induced dilation (SNPID)] of skin microvascular blood flow were assessed by laser Doppler flowmetry in pre- and post-acute exhausting exercise (AEE) sessions. Blood pressure, serum lipid, free fatty acids profiles, and biomarkers of oxidative stress were measured before and after each dietary protocol. Consumption of serum n-3 PUFAs significantly decreased the n-6/n-3 ratio and enhanced PORH and AChID, but did not affect SNPID at rest. Furthermore, serum glutathione peroxidase and superoxide dismutase activities were significantly decreased in the n-3 PUFAs group but remained unchanged in the control group. In both groups, PORH, AChID, and SNP were significantly reduced post-AEE compared with pre-AEE, both before and after consumption of each diet. Only AChID responsiveness to AEE (ΔAChID) significantly increased following consumption of n-3 PUFAs. Overall, n-3 PUFAs supplementation as n-3 PUFA-enriched hen eggs enhanced microvascular endothelial function at rest and may contribute to adaptation to AEE in competitive athletes.Entities:
Keywords: athletes; endothelium; microcirculation; n-3 polyunsaturated fatty acids; oxidative stress
Year: 2021 PMID: 35047435 PMCID: PMC8747964 DOI: 10.3746/pnf.2021.26.4.388
Source DB: PubMed Journal: Prev Nutr Food Sci ISSN: 2287-1098
Fig. 1Study timeline and protocol. PUFA, polyunsaturated fatty acid; BP, blood pressure; HR, heart rate; BMI, body mass index; WHR, waist-to-hip ratio; LDF, laser Doppler flowmetry; AEE, acute exhausting exercise session.
The effect of regular (control group) and n-3 PUFA-enriched (n-3 PUFAs group) hen egg consumption on anthropometric, hemodynamic, and biochemical parameters
| Parameter | Control | n-3 PUFA | |||
|---|---|---|---|---|---|
|
|
| ||||
| Before | After | Before | After | ||
| N (F/M) | 9 (0/9) | 14 (3/11) | |||
| Age (yr) | 22±2 | 22±3 | |||
| BMI (kg/m2) | 24.7±1.6 | 24.7±1.7 | 23.5±2.1 | 23.4±2.1 | |
| WHR | 0.86±0.05 | 0.85±0.07 | 0.81±0.05 | 0.81±0.05 | |
| SBP (mmHg) | 120±8 | 114±13 | 123±13 | 121±12 | |
| DBP (mmHg) | 72±8 | 66±12 | 73±7 | 70±7 | |
| MAP (mmHg) | 88±7 | 82±11 | 89±8 | 87±8 | |
| HR (beat/min) | 80±12 | 74±18 | 66±11 | 70±14 | |
| Erythrocytes (×10e12/L) | 4.9±0.3 | 4.9±0.3 | 4.9±0.4 | 4.9±0.3 | |
| Hemoglobin (g/L) | 146±6 | 147±6 | 147±9 | 145±7 | |
| Hematocrit (%) | 41.9±1.8 | 42.3±1.6 | 42.5±2.0 | 40.8±2.8 | |
| Leukocytes (×10e9/L) | 6.6±1.1 | 7.0±1.8 | 6.4±2.2 | 6.3±2.7 | |
| Thrombocytes (×10e9/L) | 204±28 | 217±42 | 209±48 | 207±44 | |
| Urea (mmol/L) | 6.9±1.4 | 7.1±1.2 | 6.5±1.3 | 6.8±1.4 | |
| Creatinine (mmol/L) | 90±7 | 89±8 | 88±16 | 85±15 | |
| Sodium (mmol/L) | 137.9±2.2 | 139.8±2.8 | 137.5±2.1 | 137.9±2.2 | |
| Potassium (mmol/L) | 4.3±0.4 | 4.2±0.3 | 3.9±0.6 | 3.9±0.5 | |
| Glucose (mmol/L) | 4.9±0.8 | 5.1±1.4 | 4.8±0.5 | 4.8±0.5 | |
| hsCRP (mg/L) | 0.67±1.09 | 0.90±1.25 | 0.72±1.11 | 1.15±1.39 | |
| von Willebrand factor | 1.26±0.14 | 1.45±0.30 | 1.37±0.59 | 1.33±0.46 | |
| Total cholesterol (mmol/L) | 4.4±0.4 | 4.4±0.7 | 4.4±0.4 | 4.7±0.5 | |
| Triglycerides (mmol/L) | 1.0±0.5 | 1.4±0.7 | 1.0±0.5 | 1.1±0.5 | |
| HDL cholesterol (mmol/L) | 1.4±0.2 | 1.4±0.3 | 1.4±0.2 | 1.5±0.2 | |
| LDL cholesterol (mmol/L) | 2.5±0.2 | 2.5±0.4 | 2.5±0.2 | 2.7±0.4 | |
Values are presented as mean±SD.
PUFA, polyunsaturated fatty acid; N, number of participants; F, female; M, male; BMI, body mass index; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate; hsCRP, high-sensitivity C reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
The effect of regular (control group) and n-3 PUFA-enriched (n-3 PUFAs group) hen egg consumption on serum fatty acids profiles
| Parameter | Control | n-3 PUFAs | |||
|---|---|---|---|---|---|
|
|
| ||||
| Before | After | Before | After | ||
| SFA (μmol/L) | |||||
| C14:0 Myristic acid | 30.5±0.8 | 36.9±19.1 | 28.3±4.1 | 24.0±7.6 | |
| C16:0 Palmitic acid | 376±79 | 591±287 | 341±97 | 337±62 | |
| C18:0 Stearic acid | 115±18 | 172±69 | 101±25 | 105±20 | |
| PUFA (μmol/L) | |||||
| n-7 | |||||
| C16:1(cis-9) Palmitoleic acid | 26.9±5.1 | 43.9±23.3 | 28.9±7.1 | 27.5±1.5 | |
| n-9 | |||||
| 18:1(cis-9) Oleic acid | 298±142 | 496±257 | 214±71 | 212±40 | |
| n-6 | |||||
| C18:2(cis-9,12) Linoleic acid | 597±132 | 903±337 | 460±144 | 468±129 | |
| C18:3(cis-6,9,12) Gamma-Linolenic acid | 12.7±4.2 | 13.4±2.0 | 12.1±0.3 | 11.5±0.1 | |
| C20:3(cis-8,11,14) Dihomo-gamma-linolenic acid | 23.6±4.2 | 28.9±9.3 | 23.9±6.0 | 23.3±8.4 | |
| C20:4(cis-5,8,11,14) Arachidonic acid | 161±51 | 224±58[ | 128±25 | 126±21 | |
| n-3 | |||||
| C18:3(cis-9,12,15) Alpha-Linolenic acid | <LOQ | 15.4±8.6 | 11.5±1.1 | 16.6±4.4 | |
| C20:4(cis-5,8,11,14) Eicosa-5,8,11,14,17-pentaenoic acid | <LOQ | 9, 9 | 10.9±2.5 | 13, 6 | |
| C22:6(cis-4,7,10,13,16,19) cis-4,7,10,13,16,19-Docosahexaenoic acid | 25.4±7.5 | 38.2±8.2 | 21.7±7.6 | 30.4±6.8 | |
| n-6/n-3 PUFA | 8.30 | 11.20 | 10.70 | 7.90 | |
Values are presented as mean±SD.
*P<0.05 before vs. after within each group (control or n-3 PUFA); †P<0.05 difference between the groups.
PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid.
Not found: C4:0 butyric acid, C6:0 caproic acid, C8:0 caprylic acid, C11:0 undecylic acid, C21:0 heneicosanoic acid, C15:1(cis-10) cis-10-pentadecenoic acid, C17:1(cis-10) cis-10-heptadecenoic acid, C18:1(trans-9) elaidic acid, C18:2(trans-9,12) linoelaidic acid, C22:2(cis-13,16) 13,16-docosadienoic acid, C20:3(cis-11,14,17) 11,14,17-eicosatrienoic acid.
Fig. 2Effect of regular (control group, n=9) and n-3 polyunsaturated fatty acid (PUFA)-enriched (n-3 PUFAs group, n=14) hen egg consumption on skin microvascular overall reactivity, and endothelium-dependent and -independent vasodilation in competitive athletes. (A) Post-occlusive reactive hyperemia (PORH), (B) acetylcholine-induced dilation (AChID), and (C) sodium nitroprusside-induced dilation (SNPID). PORH measurements are expressed as the difference between percentages of flow change during reperfusion and occlusion in relation to baseline (R-O%). AChID and SNPID are expressed as flow increases following ACh or SNP administration compared with baseline flow. Data are presented as arithmetic mean±SD. *P=0.002 (for PORH) and P=0.050 (for AChID) before vs. after within the n-3 PUFA group (paired t-tests).
Fig. 3Effect of regular (control group, n=9) and n-3 polyunsaturated fatty acid (PUFA)-enriched (n-3 PUFA group, n=14) hen egg consumption on skin microvascular responsiveness range to acute exhausting exercise (AEE) sessions in competitive athletes. (A) Difference in post occlusive reactive hyperemia (PORH) responsiveness, ΔPORH=PORHpost-AEE−PORHpre-AEE, (B) difference in acetylcholine-induced dilation (AChID) responsiveness, ΔAChID=AChIDpost-AEE−AChIDpre-AEE, and (C) difference in sodium nitroprusside-induced dilation (SNPID) responsiveness, ΔSNPID=SNPIDpost-AEE−SNPIDpre-AEE. PORH measurements are expressed as the difference between percentage of flow change during reperfusion and occlusion in relation to baseline (R-O%). AChID and SNPID are expressed as flow increase following ACh or SNP administration compared to baseline flow. Data are presented as arithmetic mean±SD. *P=0.008 (for ΔAChID) before vs. after within the n-3 PUFA group (paired t-test).
The effect of regular (control group) and n-3 PUFA-enriched (n-3 PUFAs group) hen egg consumption on oxidative stress levels, antioxidant defense, and antioxidant enzymes activity
| Parameter | Control | n-3 PUFAs | |||
|---|---|---|---|---|---|
|
|
| ||||
| Before | After | Before | After | ||
| TBARS (mM/L TE) | 0.30±0.07 | 0.31±0.05 | 0.35±0.15 | 0.35±0.10 | |
| FRAP (μm/MDA) | 0.33±0.04 | 0.40±0.11 | 0.33±0.04 | 0.33±0.04 | |
| CAT (U/mg protein) | 3.511±2.417 | 3.624±1.082 | 2.439±1.381 | 3.059±0.986 | |
| GPx (U/mg protein) | 0.012±0.010 | 0.009±0.004 | 0.012±0.004 | 0.006±0.003 | |
| SOD (U/mg protein) | 8.964±0.624 | 8.634±0.883 | 9.289±0.581 | 8.318±0.853 | |
Data are presented as mean±SD.
*P<0.05 before vs. after within each group (control or n-3 PUFA).
PUFA, polyunsaturated fatty acid; TBARS, thiobarbituric acid reactive substances; FRAP, ferric reducing ability of plasma; TE, Trolox equivalent; MDA, malondialdehyde; CAT, catalase; GPx, glutathione peroxidase; SOD, superoxide dismutase.